Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free STEX Stock Alerts

Biosig Technologies (STEX) Competitors

Biosig Technologies logo
$0.84 +0.04 (+5.25%)
As of 04:00 PM Eastern
Compare

STEX vs. ECC, GTEN, APXT, GLAD, and MBAV

Should you buy Biosig Technologies stock or one of its competitors? Biosig Technologies's main competitors and comparable companies include Eagle Point Credit (ECC), Gores Holdings X, Inc. / CI (GTEN), Apex Technology Acquisition (APXT), Gladstone Capital (GLAD), and M3-Brigade Acquisition V (MBAV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry.

How does Biosig Technologies compare to Eagle Point Credit?

Eagle Point Credit (NYSE:ECC) and Biosig Technologies (NASDAQ:STEX) are both small-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, institutional ownership, analyst recommendations, profitability and media sentiment.

Eagle Point Credit has a beta of 0.36, meaning that its stock price is 64% less volatile than the broader market. Comparatively, Biosig Technologies has a beta of 1.98, meaning that its stock price is 98% more volatile than the broader market.

In the previous week, Eagle Point Credit had 1 more articles in the media than Biosig Technologies. MarketBeat recorded 2 mentions for Eagle Point Credit and 1 mentions for Biosig Technologies. Biosig Technologies' average media sentiment score of 1.87 beat Eagle Point Credit's score of 1.29 indicating that Biosig Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
Eagle Point Credit Positive
Biosig Technologies Very Positive

Biosig Technologies has a net margin of 0.00% compared to Eagle Point Credit's net margin of -87.16%. Eagle Point Credit's return on equity of -1.09% beat Biosig Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Eagle Point Credit-87.16% -1.09% -0.61%
Biosig Technologies N/A -717.92%-336.75%

Eagle Point Credit has higher revenue and earnings than Biosig Technologies. Biosig Technologies is trading at a lower price-to-earnings ratio than Eagle Point Credit, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eagle Point Credit$203.99M2.49-$115M$0.675.73
Biosig Technologies$40K3,805.53-$462.77M-$9.71N/A

Eagle Point Credit currently has a consensus target price of $6.50, suggesting a potential upside of 69.27%. Biosig Technologies has a consensus target price of $8.00, suggesting a potential upside of 855.45%. Given Biosig Technologies' higher possible upside, analysts clearly believe Biosig Technologies is more favorable than Eagle Point Credit.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Eagle Point Credit
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60
Biosig Technologies
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

19.5% of Eagle Point Credit shares are held by institutional investors. Comparatively, 7.2% of Biosig Technologies shares are held by institutional investors. 0.3% of Eagle Point Credit shares are held by company insiders. Comparatively, 52.7% of Biosig Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Eagle Point Credit beats Biosig Technologies on 10 of the 16 factors compared between the two stocks.

How does Biosig Technologies compare to Gores Holdings X, Inc. / CI?

Gores Holdings X, Inc. / CI (NASDAQ:GTEN) and Biosig Technologies (NASDAQ:STEX) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

In the previous week, Gores Holdings X, Inc. / CI and Gores Holdings X, Inc. / CI both had 1 articles in the media. Gores Holdings X, Inc. / CI's average media sentiment score of 1.89 beat Biosig Technologies' score of 1.87 indicating that Gores Holdings X, Inc. / CI is being referred to more favorably in the media.

Company Overall Sentiment
Gores Holdings X, Inc. / CI Very Positive
Biosig Technologies Very Positive

Gores Holdings X, Inc. / CI's return on equity of -30.60% beat Biosig Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Gores Holdings X, Inc. / CIN/A -30.60% 2.47%
Biosig Technologies N/A -717.92%-336.75%

Biosig Technologies has a consensus target price of $8.00, suggesting a potential upside of 855.45%. Given Biosig Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Biosig Technologies is more favorable than Gores Holdings X, Inc. / CI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Gores Holdings X, Inc. / CI
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Biosig Technologies
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Gores Holdings X, Inc. / CI has higher earnings, but lower revenue than Biosig Technologies. Biosig Technologies is trading at a lower price-to-earnings ratio than Gores Holdings X, Inc. / CI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Gores Holdings X, Inc. / CIN/AN/A$920K$0.1476.39
Biosig Technologies$40K3,805.53-$462.77M-$9.71N/A

Gores Holdings X, Inc. / CI has a beta of 0.1, meaning that its stock price is 90% less volatile than the broader market. Comparatively, Biosig Technologies has a beta of 1.98, meaning that its stock price is 98% more volatile than the broader market.

7.2% of Biosig Technologies shares are owned by institutional investors. 52.7% of Biosig Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Biosig Technologies beats Gores Holdings X, Inc. / CI on 7 of the 13 factors compared between the two stocks.

How does Biosig Technologies compare to Apex Technology Acquisition?

Biosig Technologies (NASDAQ:STEX) and Apex Technology Acquisition (NASDAQ:APXT) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations and institutional ownership.

Apex Technology Acquisition has lower revenue, but higher earnings than Biosig Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biosig Technologies$40K3,805.53-$462.77M-$9.71N/A
Apex Technology AcquisitionN/AN/A-$60.72MN/AN/A

7.2% of Biosig Technologies shares are owned by institutional investors. Comparatively, 6.0% of Apex Technology Acquisition shares are owned by institutional investors. 52.7% of Biosig Technologies shares are owned by insiders. Comparatively, 21.1% of Apex Technology Acquisition shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Biosig Technologies presently has a consensus price target of $8.00, suggesting a potential upside of 855.45%. Given Biosig Technologies' stronger consensus rating and higher possible upside, research analysts plainly believe Biosig Technologies is more favorable than Apex Technology Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biosig Technologies
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Apex Technology Acquisition
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Apex Technology Acquisition had 2 more articles in the media than Biosig Technologies. MarketBeat recorded 3 mentions for Apex Technology Acquisition and 1 mentions for Biosig Technologies. Biosig Technologies' average media sentiment score of 1.87 beat Apex Technology Acquisition's score of 0.75 indicating that Biosig Technologies is being referred to more favorably in the media.

Company Overall Sentiment
Biosig Technologies Very Positive
Apex Technology Acquisition Positive

Biosig Technologies has a beta of 1.98, meaning that its share price is 98% more volatile than the broader market. Comparatively, Apex Technology Acquisition has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market.

Biosig Technologies' return on equity of -717.92% beat Apex Technology Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
Biosig TechnologiesN/A -717.92% -336.75%
Apex Technology Acquisition N/A -750.42%-10.63%

Summary

Biosig Technologies beats Apex Technology Acquisition on 9 of the 12 factors compared between the two stocks.

How does Biosig Technologies compare to Gladstone Capital?

Gladstone Capital (NASDAQ:GLAD) and Biosig Technologies (NASDAQ:STEX) are both small-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

In the previous week, Gladstone Capital had 2 more articles in the media than Biosig Technologies. MarketBeat recorded 3 mentions for Gladstone Capital and 1 mentions for Biosig Technologies. Biosig Technologies' average media sentiment score of 1.87 beat Gladstone Capital's score of 0.70 indicating that Biosig Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
Gladstone Capital Positive
Biosig Technologies Very Positive

10.7% of Gladstone Capital shares are owned by institutional investors. Comparatively, 7.2% of Biosig Technologies shares are owned by institutional investors. 3.8% of Gladstone Capital shares are owned by insiders. Comparatively, 52.7% of Biosig Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Gladstone Capital has a net margin of 50.48% compared to Biosig Technologies' net margin of 0.00%. Gladstone Capital's return on equity of 9.67% beat Biosig Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Gladstone Capital50.48% 9.67% 5.00%
Biosig Technologies N/A -717.92%-336.75%

Gladstone Capital presently has a consensus target price of $21.67, suggesting a potential upside of 10.15%. Biosig Technologies has a consensus target price of $8.00, suggesting a potential upside of 855.45%. Given Biosig Technologies' higher possible upside, analysts plainly believe Biosig Technologies is more favorable than Gladstone Capital.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Gladstone Capital
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40
Biosig Technologies
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Gladstone Capital has a beta of 0.92, indicating that its stock price is 8% less volatile than the broader market. Comparatively, Biosig Technologies has a beta of 1.98, indicating that its stock price is 98% more volatile than the broader market.

Gladstone Capital has higher revenue and earnings than Biosig Technologies. Biosig Technologies is trading at a lower price-to-earnings ratio than Gladstone Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Gladstone Capital$89.12M4.99$58.11M$2.069.55
Biosig Technologies$40K3,805.53-$462.77M-$9.71N/A

Summary

Gladstone Capital beats Biosig Technologies on 11 of the 16 factors compared between the two stocks.

How does Biosig Technologies compare to M3-Brigade Acquisition V?

M3-Brigade Acquisition V (NASDAQ:MBAV) and Biosig Technologies (NASDAQ:STEX) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

7.2% of Biosig Technologies shares are owned by institutional investors. 52.7% of Biosig Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

M3-Brigade Acquisition V's return on equity of 0.00% beat Biosig Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
M3-Brigade Acquisition VN/A N/A N/A
Biosig Technologies N/A -717.92%-336.75%

M3-Brigade Acquisition V has higher earnings, but lower revenue than Biosig Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
M3-Brigade Acquisition VN/AN/AN/AN/AN/A
Biosig Technologies$40K3,805.53-$462.77M-$9.71N/A

M3-Brigade Acquisition V has a beta of 0.12, indicating that its stock price is 88% less volatile than the broader market. Comparatively, Biosig Technologies has a beta of 1.98, indicating that its stock price is 98% more volatile than the broader market.

In the previous week, Biosig Technologies had 1 more articles in the media than M3-Brigade Acquisition V. MarketBeat recorded 1 mentions for Biosig Technologies and 0 mentions for M3-Brigade Acquisition V. Biosig Technologies' average media sentiment score of 1.87 beat M3-Brigade Acquisition V's score of 0.00 indicating that Biosig Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
M3-Brigade Acquisition V Neutral
Biosig Technologies Very Positive

Biosig Technologies has a consensus price target of $8.00, suggesting a potential upside of 855.45%. Given Biosig Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Biosig Technologies is more favorable than M3-Brigade Acquisition V.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
M3-Brigade Acquisition V
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Biosig Technologies
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Biosig Technologies beats M3-Brigade Acquisition V on 9 of the 11 factors compared between the two stocks.

Get Biosig Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for STEX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STEX vs. The Competition

Export
MetricBiosig TechnologiesCapital Markets IndustryFinance SectorNASDAQ Exchange
Market Cap$144.63M$5.63B$14.01B$12.88B
Dividend YieldN/A7.39%5.88%10.73%
P/E Ratio-0.0938.0029.2025.05
Price / Sales3,805.531,267.44517.5886.36
Price / CashN/A48.3239.3750.58
Price / Book1.013.713.676.23
Net Income-$462.77M$417.15M$1.31B$347.40M
7 Day Performance15.46%0.62%0.27%1.46%
1 Month Performance-8.75%0.66%1.19%-0.49%
1 Year PerformanceN/A8.45%12.52%20.91%

Biosig Technologies Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
STEX
Biosig Technologies
2.7022 of 5 stars		$0.84
+5.3%		$8.00
+855.5%		N/A$144.63M$40KN/A50
ECC
Eagle Point Credit
3.6054 of 5 stars		$3.84
-0.9%		$6.50
+69.5%		-39.3%$511.65M$203.99M5.72N/A
GTEN
Gores Holdings X, Inc. / CI
0.9644 of 5 stars		$10.46
-0.2%		N/AN/A$472.39MN/A74.683
APXT
Apex Technology Acquisition
0.3768 of 5 stars		$10.09
-0.1%		N/A-29.4%$449.61MN/AN/AN/A
GLAD
Gladstone Capital
2.3139 of 5 stars		$19.02
+1.9%		$21.67
+13.9%		-27.4%$421.81M$46.51M10.3970

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:STEX) was last updated on 8/12/2026 by MarketBeat.com Staff.
From Our Partners
Iran War: What Happened at 1:11 P.M. Outside D.C.?
A source with ties to Saudi Arabia, the UAE, and the U.S. State Department revealed details of a potential 7 t...
Banyan Hill Publishing | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
$8B is moving in... are you?
Venture capital investment in US crypto companies hit $7.9 billion last year, up 44 percent from the year befo...
Awesomely | Sponsoredtc pixel
Nvidia's CEO says this small device is critical for AI growth
A tiny glass device smaller than a fingertip could redefine AI hardware. Nvidia CEO Jensen Huang calls it esse...
Brownstone Research | Sponsoredtc pixel